Featured Post

Latest Gold News

This analyst sees nothing to stop gold from continuing climb Cyber Terrorism another reason to own gold says Faber Fed doves supportin...

Tuesday, December 13, 2011

Onyx (ONXX) (GHDX) (GLT) (IVR) (KOP) (LNC) (NKE) Price Targets Changed

Onyx Pharmaceuticals, Inc. (NASDAQ: ONXX), Genomic Health, Inc. (NASDAQ: GHDX), P.H. Glatfelter Company (NYSE: GLT), Invesco Mortgage Capital Inc. (NYSE: IVR), Koppers Holdings (NYSE: KOP), Lincoln National Co. (NYSE: LNC) and NIKE, Inc. (NYSE: NKE) had price targets on them adjusted by analysts.

Onyx Pharmaceuticals, Inc. ( ONXX) had its price target lowered by Goldman Sachs (NYSE:GS) to $45.00. They have a “Buy” rating on the company.

Genomic Health, Inc. (NASDAQ: GHDX) had its price target raised by analysts at Ladenburg Thalmann from $26.00 to $32.00. The analysts now have a “buy” rating on the company.

P.H. Glatfelter Company (NYSE: GLT) had its price target raised by Deutsche Bank (NYSE:DB) to $19.00. They have a “Buy” rating on the company.

Invesco Mortgage Capital Inc. (IVR) had its price target lowered by Wunderlich to $16.50. They have a “Hold” rating on the company.

Koppers Holdings (KOP) had its price target lowered by Jefferies (NYSE:JEF) to $43.00.

Lincoln National Co. (LNC) had its price target raised by RBC Capital from $22.00 to $24.00. They have a “Sector Perform” rating on the company.

NIKE, Inc. (NKE) had its price target raised by Stifel Nicolaus from $98.00 to $108.00. They have a “Buy” rating on the company.

No comments: